Dr. Christopher Paul Santini, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2 Southside Rd, York, ME 03909 Phone: 207-363-0500 Fax: 207-363-0503 |
Dr. Ferida Khanjani, D.C., MPH Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 31 Old Post Rd, York, ME 03909 Phone: 207-289-9673 |
Dr. Christopher Joseph Molda, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 529 Us Route 1, Suite 4, York, ME 03909 Phone: 207-363-5656 |
Dr. John C Beddoe, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1 Brickyard Ln, Suite Bb, York, ME 03909 Phone: 207-363-5966 |
Dr. Nancy A Flolid, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1 Brickyard Ln, Suite Bb, York, ME 03909 Phone: 207-363-5966 |
Chiropractic Works, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 1 Brickyard Ln, Suite Bb, York, ME 03909 Phone: 207-363-5966 |
News Archive
Research published in the Journal of Neurosurgery: Pediatrics suggests that wearing a cycling helmet offers a child significant protection against serious impact and crushing head injuries.
A study reveals today that inadequate blood sugar control in patients having heart surgery is associated with a four fold increase in post-surgery death and major complications - and that the blood sugar disturbances occur in patients with and without diabetes.
RUCDR Infinite Biologics, the world's largest university-based biorepository, received a $44.5 million Cooperative Agreement award from the National Institute of Mental Health earlier this month to support its NIMH Center for Collaborative Genomics Research on Mental Disorders, which provides services to NIMH-funded scientists engaged in genomic research on mental disorders.
Extended use of a common antibiotic may prolong the time between hospitalizations for patients suffering from chronic obstructive pulmonary disease, according to a post-hoc analysis of a multicenter study which compared the hospitalization rates of patients treated with a 12-month course of azithromycin to the rates of those treated with placebo.
Regeneron Pharmaceuticals, Inc. today announced that results from the National Institutes of Health-sponsored, Diabetic Retinopathy Clinical Research Network comparative effectiveness study in patients with Diabetic Macular Edema (Protocol T) were published in the New England Journal of Medicine and a corresponding slide set was posted online at DRCR.net.
› Verified 9 days ago